Mevastatin hydroxy acid sodium salt
CAS: 99782-89-5
Ref. 3D-FM25992
| 10mg | Descontinuado | ||
| 25mg | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado |
Informação sobre produto
Nome:
Mevastatin hydroxy acid sodium salt
Sinónimos:
- (b-R,?R,1S,2S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-b,?-dihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid sodium salt[1S-[1a(b-S*,?S*),2a,8b(R*),8a-a]]-1,2,6,7,8,8a-Hexahydro-b,?-dihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naph
Descrição:
Mevastatin is a cholesterol-lowering drug that belongs to the class of hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. It is used in the treatment of hypercholesterolemia, which is an excess of cholesterol in the blood. Mevastatin inhibits the biosynthesis of cholesterol by competitively inhibiting HMG-CoA reductase, which is an enzyme involved in the production of mevalonic acid from acetyl-CoA and acetoacetyl-CoA. This drug also inhibits the synthesis of pravastatin through a cytochrome P450 enzyme system. Mevastatin has been shown to inhibit transcriptional regulation in human skin fibroblasts and to downregulate mRNA levels for gene products involved in cellular proliferation.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
430.51 g/mol
Fórmula:
C23H35NaO6
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
